TY - JOUR
T1 - Identifying kinase targets of PPARγ in human breast cancer
AU - Kandel, Anish
AU - Dhillon, Sarinder Kaur
AU - Prabaharan, Chandra Bose
AU - Fatnin Binti Hisham, Syaza
AU - Rajamanickam, Karthic
AU - Napper, Scott
AU - Chidambaram, Saravana Babu
AU - Essa, Musthafa Mohamed
AU - Yang, Jian
AU - Sakharkar, Meena Kishore
N1 - Funding Information:
This research was funded by Natural Sciences and Engineering Research Council (Canada), Grant no. 417652 (M.K.S.) and College of Pharmacy and Nutrition, University of Saskatchewan (Canada), Grant no. 415458 (M.K.S.).
Publisher Copyright:
© 2021 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2021
Y1 - 2021
N2 - Breast cancer is the most common cancer in women. Despite advances in screening women for genetic predisposition to breast cancer and risk stratification, a majority of women carriers remain undetected until they become affected. Thus, there is a need to develop a cost-effective, rapid, sensitive and non-invasive early-stage diagnostic method. Kinases are involved in all fundamental cellular processes and mutations in kinases have been reported as drivers of cancer. PPARγ is a ligand-activated transcription factor that plays important roles in cell proliferation and metabolism. However, the complete set of kinases modulated by PPARγ is still unknown. In this study, we identified human kinases that are potential PPARγ targets and evaluated their differential expression and gene pair correlations in human breast cancer patient dataset TCGA-BRCA. We further confirmed the findings in human breast cancer cell lines MCF7 and SK-BR-3 using a kinome array. We observed that gene pair correlations are lost in tumours as compared to healthy controls and could be used as a supplement strategy for diagnosis and prognosis of breast cancer.
AB - Breast cancer is the most common cancer in women. Despite advances in screening women for genetic predisposition to breast cancer and risk stratification, a majority of women carriers remain undetected until they become affected. Thus, there is a need to develop a cost-effective, rapid, sensitive and non-invasive early-stage diagnostic method. Kinases are involved in all fundamental cellular processes and mutations in kinases have been reported as drivers of cancer. PPARγ is a ligand-activated transcription factor that plays important roles in cell proliferation and metabolism. However, the complete set of kinases modulated by PPARγ is still unknown. In this study, we identified human kinases that are potential PPARγ targets and evaluated their differential expression and gene pair correlations in human breast cancer patient dataset TCGA-BRCA. We further confirmed the findings in human breast cancer cell lines MCF7 and SK-BR-3 using a kinome array. We observed that gene pair correlations are lost in tumours as compared to healthy controls and could be used as a supplement strategy for diagnosis and prognosis of breast cancer.
KW - breast cancer
KW - differential expression gene
KW - gene pair correlation
KW - kinase
KW - PPARγ
UR - http://www.scopus.com/inward/record.url?scp=85102260154&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85102260154&partnerID=8YFLogxK
U2 - 10.1080/1061186X.2021.1877719
DO - 10.1080/1061186X.2021.1877719
M3 - Article
C2 - 33496213
AN - SCOPUS:85102260154
SN - 1061-186X
VL - 29
SP - 660
EP - 668
JO - Journal of Drug Targeting
JF - Journal of Drug Targeting
IS - 6
ER -